Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Oral Therapy 1.4.3 Injectable Therapy 1.5 Market by Application 1.5.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2025) 1.5.2 Hospitals & Clinics 1.5.3 Home Settings 1.5.4 Ambulatory Surgical Centers (ASCs) 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Growth Trends by Regions 2.2.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions (2014-2025) 2.2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Manufacturers 3.1.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players Head office and Area Served 3.3 Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product/Solution/Service 3.4 Date of Enter into Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) 4.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019) 5.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in United States 5.3 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type 5.4 United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application 6 Europe 6.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019) 6.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in Europe 6.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type 6.4 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application 7 China 7.1 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019) 7.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in China 7.3 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type 7.4 China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application 8 Japan 8.1 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019) 8.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in Japan 8.3 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type 8.4 Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019) 9.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type 9.4 Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application 10 India 10.1 India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019) 10.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in India 10.3 India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type 10.4 India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2014-2019) 11.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players in Central & South America 11.3 Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type 11.4 Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application 12 International Players Profiles 12.1 Astellas Inc. 12.1.1 Astellas Inc. Company Details 12.1.2 Company Description and Business Overview 12.1.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction 12.1.4 Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) 12.1.5 Astellas Inc. Recent Development 12.2 Johnson & Johnson 12.2.1 Johnson & Johnson Company Details 12.2.2 Company Description and Business Overview 12.2.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction 12.2.4 Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) 12.2.5 Johnson & Johnson Recent Development 12.3 Sanofi S.A 12.3.1 Sanofi S.A Company Details 12.3.2 Company Description and Business Overview 12.3.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction 12.3.4 Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) 12.3.5 Sanofi S.A Recent Development 12.4 Dendreon Corporation 12.4.1 Dendreon Corporation Company Details 12.4.2 Company Description and Business Overview 12.4.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction 12.4.4 Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) 12.4.5 Dendreon Corporation Recent Development 12.5 Bayer AG 12.5.1 Bayer AG Company Details 12.5.2 Company Description and Business Overview 12.5.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction 12.5.4 Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) 12.5.5 Bayer AG Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Market Segments Table Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Covered Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type 2014-2025 Figure Oral Therapy Figures Table Key Players of Oral Therapy Figure Injectable Therapy Figures Table Key Players of Injectable Therapy Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals & Clinics Case Studies Figure Home Settings Case Studies Figure Ambulatory Surgical Centers (ASCs) Case Studies Figure Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Report Years Considered Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2025 (Million US$) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions 2014-2019 Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions 2014-2019 Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Manufacturers in 2018 Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product/Solution/Service Table Date of Enter into Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Type (2014-2019) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2014-2019) Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Application (2014-2019) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Application in 2018 Figure United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019) Table United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019) Table United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019) Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019) Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019) Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019) Figure China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019) Table China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019) Table China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019) Figure Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019) Table Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019) Table Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019) Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019) Figure India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019) Table India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019) Table India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019) Figure Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share (2018-2019) Table Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Type (2014-2019) Table Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application (2014-2019) Table Astellas Inc. Company Details Table Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) (Million US$) Figure Astellas Inc. Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) Table Astellas Inc. Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) Table Johnson & Johnson Recent Development Table Sanofi S.A Company Details Table Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)(Million US$) Figure Sanofi S.A Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) Table Sanofi S.A Recent Development Table Dendreon Corporation Company Details Table Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)(Million US$) Figure Dendreon Corporation Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) Table Dendreon Corporation Recent Development Table Bayer AG Company Details Table Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019)(Million US$) Figure Bayer AG Revenue Growth Rate in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2014-2019) Table Bayer AG Recent Development Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Regions (2019-2025) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Share by Regions in 2025 Figure United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Product (2019-2025) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Product in 2025 Table Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2019-2025) Figure Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Astellas Inc. Johnson & Johnson Sanofi S.A Dendreon Corporation Bayer AG